NMC delays action against 30 doctors accused in pharma freebies case
- byDoctor News Daily Team
- 26 October, 2025
- 0 Comments
- 0 Mins
Nearly 10 months have passed since the Department of Pharmaceuticals (DoP) recommended disciplinary action against 30 doctors accused of accepting pharma-sponsored foreign trips worth Rs 1.91 crore to Monaco and Paris, theNational Medical Commission (NMC)is yet to take a decision on the matter. The case continues to remain under consideration with the Ethics and Medical Registration Board (EMRB), which is currently facing vacancies in key positions. For more details, check out the full story on the link mentioned below: NMC yet to take action against 30 doctors in pharma freebies case
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
NEET counselling: Maha CET Cell notifies revised r...
- 26 October, 2025
AYUSH Ministry, ICMR to host national seminar on l...
- 26 October, 2025
Dermatologists urge Maha Medical Council to crackd...
- 26 October, 2025
Illegal sex determination racket busted in Mysuru,...
- 26 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!